Improving care quality and equity for serious mental illness in Medicaid
Addressing Gaps in the Evidence to Improve Quality, Equity, and Value of Serious Mental Illness Care in Medicaid
This study looks at how well people with serious mental illness who have Medicaid are getting care, especially considering how things like race and ethnicity might affect their health, and it aims to find ways to make that care better and fairer for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-11063152 on NIH RePORTER |
What this research studies
This research investigates the quality and accessibility of care for individuals with serious mental illness (SMI) who are covered by Medicaid. It aims to identify gaps in current care practices and policies, particularly focusing on how factors like race and ethnicity affect health outcomes. By analyzing data on care delivery, including the impact of telehealth services post-COVID-19, the research seeks to provide policymakers with the necessary information to enhance the quality and equity of SMI care. The ultimate goal is to develop targeted interventions that can improve patient outcomes and reduce disparities in care.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are receiving Medicaid for serious mental illnesses such as bipolar disorder.
Not a fit: Patients who do not have serious mental illnesses or are not covered by Medicaid may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved quality of care and better health outcomes for individuals with serious mental illness covered by Medicaid.
How similar studies have performed: Previous research has shown that addressing quality and equity in mental health care can lead to significant improvements in patient outcomes, indicating that this approach has potential for success.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Horvitz-Lennon, Marcela V — Rand Corporation
- Study coordinator: Horvitz-Lennon, Marcela V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.